Mode
Text Size
Log in / Sign up

Sarcopenia linked to higher acute cholecystitis risk in older adults with incidental gallstones

Sarcopenia linked to higher acute cholecystitis risk in older adults with incidental gallstones
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider sarcopenia as a potential risk marker for acute cholecystitis in older adults with gallstones.

This retrospective cohort study analyzed 1,177 patients aged 65 years or older who had incidentally detected gallstones and no prior biliary disease. The exposure was sarcopenia, assessed via handgrip strength and appendicular skeletal muscle mass, compared to non-sarcopenic patients. The primary outcome was the development of incident acute cholecystitis (AC).

Over the study period, 336 patients (28.5%) developed AC. Sarcopenia was significantly associated with AC development, with an odds ratio of 3.564 (95% CI: 2.619–4.860) and a hazard ratio of 2.419 (95% CI: 1.912–3.060; p < 0.001). Sarcopenia prevalence was 38.10% in the AC group versus 14.03% in those without AC (p < 0.001). Mean handgrip strength was lower in the AC group (22.92 ± 12.51 kg vs. 25.50 ± 12.44 kg; p < 0.001), as was appendicular skeletal muscle mass (6.82 ± 2.74 kg/m² vs. 7.67 ± 2.93 kg/m²; p < 0.001). AC-free survival was significantly reduced in sarcopenic patients (log-rank p < 0.001).

Safety and tolerability data were not reported. Key limitations include the retrospective, observational design, which precludes establishing causality, and the lack of reported follow-up duration. The study population was limited to older adults with incidental gallstones. The authors suggest sarcopenia may independently predict AC development and that routine assessment could identify high-risk individuals for targeted interventions. However, this remains a hypothesis generated from observational data.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundThis study investigated whether sarcopenia independently predicts incident acute cholecystitis (AC) in geriatric patients with gallstones.MethodsThis retrospective cohort study included 1,177 patients aged ≥65 years with incidentally detected gallstones and no prior biliary disease. Sarcopenia was diagnosed using Asian Working Group for Sarcopenia 2019 criteria. The primary outcome was AC development during follow-up, adjudicated using Tokyo Guidelines 2018. Multivariate logistic and Cox regression models adjusted for age, BMI, sex, alcoholism, and Charlson Comorbidity Index.7ResultsDuring follow-up, 336 patients (28.5%) developed AC. The AC group exhibited significantly higher sarcopenia prevalence (38.10 vs. 14.03%; p < 0.001) and lower mean handgrip strength (22.92 ± 12.51 vs. 25.50 ± 12.44 kg; p < 0.001) and appendicular skeletal muscle mass (6.82 ± 2.74 vs. 7.67 ± 2.93 kg/m2; p < 0.001) compared to controls. Sarcopenia independently increased AC risk by 3.56-fold (OR = 3.564, 95%CI: 2.619–4.860; p < 0.001) and AC hazard by 2.42-fold (HR = 2.419, 95%CI: 1.912–3.060; p < 0.001). Kaplan-Meier analysis demonstrated significantly reduced AC-free survival in sarcopenic patients (log-rank p < 0.001). Severe sarcopenia did not confer additional risk beyond standard sarcopenia criteria.ConclusionsSarcopenia is a robust, independent predictor of AC development in older adults with gallstones, offering superior risk stratification compared to adiposity-based metrics. Routine sarcopenia assessment may identify high-risk individuals for targeted preventive interventions.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.